Articles written by: Edward Rupert

Comparison of AmpliPhi Biosciences Corporation (APHB) and Endocyte Inc. (NASDAQ:ECYT).

We are contrasting AmpliPhi Biosciences Corporation (NYSEAMERICAN:APHB) and Endocyte Inc. (NASDAQ:ECYT) on their analyst recommendations, profitability, risk, institutional ownership, dividends, earnings and valuation. They both are Biotechnology companies, competing one another. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AmpliPhi Biosciences Corporation N/A 417.40 […]

Aemetis Inc. (AMTX)’s Financial Results Comparing With Amyris Inc. (NASDAQ:AMRS).

We are contrasting Aemetis Inc. (NASDAQ:AMTX) and Amyris Inc. (NASDAQ:AMRS) on their dividends, analyst recommendations, profitability, institutional ownership, risk, earnings and valuation. They both are Specialty Chemicals companies, competing one another. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aemetis Inc. 171.56M 0.13 29.87M […]

Forward Pharma A/S (FWP) and Akebia Therapeutics Inc. (NASDAQ:AKBA) Contrasting side by side.

As Biotechnology companies, Forward Pharma A/S (NASDAQ:FWP) and Akebia Therapeutics Inc. (NASDAQ:AKBA) are our subject to compare. And more specifically their risk, analyst recommendations, institutional ownership, profitability, dividends, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Forward Pharma A/S N/A 0.00 […]

Albireo Pharma Inc. (ALBO) and Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Contrasting side by side.

We are contrasting Albireo Pharma Inc. (NASDAQ:ALBO) and Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) on their profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation. They both are Biotechnology companies, competing one another. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Albireo Pharma Inc. 12.17M […]

Poage Bankshares Inc. (PBSK) and SI Financial Group Inc. (NASDAQ:SIFI) Comparing side by side.

As Savings & Loans companies, Poage Bankshares Inc. (NASDAQ:PBSK) and SI Financial Group Inc. (NASDAQ:SIFI) are our subject to contrast. And more specifically their dividends, analyst recommendations, profitability, risk, earnings and valuation, institutional ownership. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Poage Bankshares […]

Blueknight Energy Partners L.P. (BKEPP)’s Financial Results Comparing With Roan Resources Inc. (NYSE:ROAN).

As Independent Oil & Gas companies, Blueknight Energy Partners L.P. (NASDAQ:BKEPP) and Roan Resources Inc. (NYSE:ROAN) are our subject to contrast. And more specifically their analyst recommendations, profitability, institutional ownership, risk, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Blueknight […]

Aurinia Pharmaceuticals Inc. (AUPH) and Apellis Pharmaceuticals Inc. (NASDAQ:APLS) Comparing side by side.

Both Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) and Apellis Pharmaceuticals Inc. (NASDAQ:APLS) are Biotechnology companies, competing one another. We will compare their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aurinia Pharmaceuticals Inc. N/A 1387.12 52.86M […]

Reviewing Achillion Pharmaceuticals Inc. (ACHN)’s and EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT)’s results.

We are comparing Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) and EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT) on their dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation. They both are Biotechnology companies, competing one another. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Achillion Pharmaceuticals Inc. N/A […]

Enanta Pharmaceuticals Inc. (ENTA)’s Financial Results Comparing With Phio Pharmaceuticals Corp. (NASDAQ:PHIO).

We are comparing Enanta Pharmaceuticals Inc. (NASDAQ:ENTA) and Phio Pharmaceuticals Corp. (NASDAQ:PHIO) on their profitability, analyst recommendations, institutional ownership, risk, dividends, earnings and valuation. They both are Biotechnology companies, competing one another. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Enanta Pharmaceuticals Inc. 206.62M […]

Comparison of NuCana plc (NCNA) and Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY).

NuCana plc (NASDAQ:NCNA) and Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), both competing one another are Biotechnology companies. We will contrast their risk, analyst recommendations, institutional ownership, profitability, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NuCana plc N/A 0.00 20.19M -0.58 0.00 […]